Schiel MA

References (3)

Title : Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53 - Chiorean_2012_Cancer.Chemother.Pharmacol_70_25
Author(s) : Chiorean EG , Sanghani S , Schiel MA , Yu M , Burns M , Tong Y , Hinkle DT , Coleman N , Robb B , LeBlanc J , Clark R , Bufill J , Curie C , Loehrer PJ , Cardenes H
Ref : Cancer Chemother Pharmacol , 70 :25 , 2012
Abstract :
PubMedSearch : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25
PubMedID: 22610353

Title : Human carboxylesterases: an update on CES1, CES2 and CES3 - Sanghani_2009_Protein.Pept.Lett_16_1207
Author(s) : Sanghani SP , Sanghani PC , Schiel MA , Bosron WF
Ref : Protein Pept Lett , 16 :1207 , 2009
Abstract :
PubMedSearch : Sanghani_2009_Protein.Pept.Lett_16_1207
PubMedID: 19508181
Gene_locus related to this paper: human-CES1 , human-CES2 , human-CES3

Title : Expression and characterization of a human carboxylesterase 2 splice variant - Schiel_2007_J.Pharmacol.Exp.Ther_323_94
Author(s) : Schiel MA , Green SL , Davis WI , Sanghani PC , Bosron WF , Sanghani SP
Ref : Journal of Pharmacology & Experimental Therapeutics , 323 :94 , 2007
Abstract :
PubMedSearch : Schiel_2007_J.Pharmacol.Exp.Ther_323_94
PubMedID: 17636009